Asia Pacific Hemostats Market Research Report - Segmented By Product Type, Application, Distribution Channel and Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore, and Rest of APAC) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2022 to 2027)
APAC Hemostats Market Size (2022 to 2027)
The Hemostats market size in the Asia Pacific was valued at around USD 726.92 million in 2022. It is further expected to be growing at a CAGR of 6.9% from 2022 to 2027 and worth USD 1014.79 million by 2027. Thus, the Asia Pacific is set on a high growth trajectory in the forecast above period. The reasons behind the booming medical tourism industry, rising disposable income resulting in higher purchasing power and rising awareness regarding better health infrastructure. It captures 20% of the global market.
Y-O-Y growth in the aging population in India and China, the growing number of surgical procedures, and trauma cases are estimated to drive the hemostats market growth in Asia-Pacific. Additionally, an increasing number of FDA approval processes, rising medical tourism industry, enhancing medical healthcare infrastructure are expected to favor the market growth of hemostats in the Asia Pacific. Growing discretionary expenses, increasing investments for healthcare, and reimbursement scenarios are contributing support to the market.
Rigorous regulatory procedures, less awareness regarding the benefits associated with the hemostats products, and the high cost of hemostats equipment and treatment are majorly restraining the market growth in the Asia Pacific. In addition, rules and regulations made of APAC governments and experienced professionals' needs are significant challenges hindering the development.
This research report on the APAC Hemostats Market has been segmented and sub-segmented into the following categories:
By Product Type:
- Topical Hemostats
- Tissue Sealants
- Cyanoacrylate-based Tissue Adhesives
- Adhesion Prevention Products
By Application:
- Wound Closure
- Surgical Hemostats
By Distribution Channel:
- Direct Tenders
- Retail
By Country:
- India
- China
- Japan
- South Korea
- Australia
- New Zealand
- Thailand
- Malaysia
- Vietnam
- Philippines
- Indonesia
- Singapore
- Rest of APAC
Regionally, the hemostats market in Asia-Pacific is the fastest-growing region globally due to the patient population with significant growth in surgical procedures and growing product launches.
The Chinese hemostats market is expected to dominate the Asia Pacific market during the forecast period. The increasing number of sports-related injuries, advanced technologies, and rising attention towards effective blood loss management in patients during surgeries are expected to drive the market.
The Indian hemostats market is anticipated to witness rapid growth during the forecast period. This is because the number of hospitals rose from 35,416 to 37,725 from 2015 to 2017; according to the Ministry of Health and Family Welfare, Government of India, healthcare amenities, the increased amount spent towards healthcare fuels the market during the forecast period.
KEY MARKET PLAYERS:
A few promising companies operating in the APAC hemostats market profiled in the report are 3M, ADCO Asia Pacific, Inc., Abbott Laboratories. Other players in the market include Advanced Medical Solutions Group, Plc, and Dymax Corporation.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product Type
5.1.1 Introduction
5.1.2 Topical hemostats
5.1.2.1 Collagen-based topical hemostats
5.1.2.2 Oxidized regenerated cellulose-based topical hemostat
5.1.2.3 Gelatin-based topical hemostat
5.1.2.4 Thrombin-based topical hemostat
5.1.2.5 Combination topical hemostat
5.1.3 Tissue Sealants
5.1.3.1 Fibrin sealants
5.1.3.2 Protein-based sealants
5.1.4 Cyanoacrylate-based tissue adhesives
5.1.5 Adhesion prevention products
5.1.6 Y-o-Y Growth Analysis, By Product Type
5.1.7 Market Attractiveness Analysis, By Product Type
5.1.8 Market Share Analysis, By Product Type
5.2 Application
5.2.1 Wound Closure
5.2.2 Surgical Hemostats
5.2.3 Y-o-Y Growth Analysis, By Application
5.2.4 Market Attractiveness Analysis, By Application
5.2.5 Market Share Analysis, By Application
5.3 Distribution Channel
5.3.1 Direct Tenders
5.3.2 Retail
5.3.3 Y-o-Y Growth Analysis, By Distribution Channel
5.3.4 Market Attractiveness Analysis, By Distribution Channel
5.3.5 Market Share Analysis, By Distribution Channel
5.4 End User
5.4.1 Hospitals
5.4.2 Ambulatory Centers
5.4.3 Community Healthcare
5.4.4 Clinics
5.4.5 Y-o-Y Growth Analysis, By End User
5.4.6 Market Attractiveness Analysis, By End User
5.4.7 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product Type
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product Type
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product Type
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Johnson & Johnson Services, Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 C. R. Bard, Inc.
8.3 Baxter
8.4 B. Braun Melsungen Ag
8.5 Pfizer Inc.
8.6 Vascular Solutions, Inc.
8.7 Gelita Medical Gmbh
8.8 Equimedical
8.9 Integra Lifesciences Holdings Corporation
8.10 Z-Medica, LLC
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
- Asia Pacific Hemostats Market, By Product Type, From 2022 - 2027 (USD Million)
- Asia Pacific Topical hemostats Market, By Region, From 2022 - 2027 (USD Million)
- Asia Pacific Tissue Sealants Market, By Region, From 2022 - 2027 (USD Million)
- Asia Pacific Cyanoacrylate-based tissue adhesives Market, By Region, From 2022 - 2027 (USD Million)
- Asia Pacific Adhesion prevention products Market, By Region, From 2022 - 2027 (USD Million)
- Japan Hemostats Market, By Product Type, From 2022 - 2027 (USD Million)
- China Hemostats Market, By Product Type, From 2022 - 2027 (USD Million)
- India Hemostats Market, By Product Type, From 2022 - 2027 (USD Million)
- Australia Hemostats Market, By Product Type, From 2022 - 2027 (USD Million)
- South Korea Hemostats Market, By Product Type, From 2022 - 2027 (USD Million)
Related Reports
ASK FOR CUSTOMIZATION
Talk to our analyst and get customised report done according to your research needs
INQUIRE FOR DISCOUNT
Check if you can avail any discount. Submit your details and our team will get back to you.
DOWNLOAD FREE SAMPLE
Request to avail a free sample report that reflects this market and its growth.
